Log in to save to my catalogue

Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined A...

Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined A...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2694417626

Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined Antioxidant Therapy

About this item

Full title

Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined Antioxidant Therapy

Publisher

Cham: Springer International Publishing

Journal title

Clinical pharmacokinetics, 2022-09, Vol.61 (9), p.1203-1218

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

The main goal of the treatment for acute myocardial infarction is to achieve reperfusion of the affected myocardial tissue, with percutaneous coronary angioplasty being the gold standard procedure. However, this strategy has been associated with additional heart damage termed “lethal reperfusion injury,” which is responsible for up to half of the f...

Alternative Titles

Full title

Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined Antioxidant Therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2694417626

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2694417626

Other Identifiers

ISSN

0312-5963

E-ISSN

1179-1926

DOI

10.1007/s40262-022-01151-0

How to access this item